Skip to content

    Nath Bio-Genes (India) Limited

    Indian hybrid-seed producer of cotton, paddy, maize and vegetable seeds, plus plant-nutrition products, sold through a pan-India distributor network.

    Fast Moving Consumer Goods
    Fast Moving Consumer Goods
    View NATHBIOGEN earnings calls

    Overview

    Price

    Market Cap

    ₹306 Cr

    Sector

    Fast Moving Consumer Goods

    Fast Moving Consumer Goods

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital1919191919191919
    Reserves539594523554592630668670
    Borrowings7010193105108111142122
    Other Liabilities10275105114158257176272
    Total Liabilities7307907407938771.0k1.0k1.1k
    AssetsFixed Assets246247245244249250249249
    CWIP00000000
    Investments55556666
    Other Assets479538490544622761750827
    Total Assets7307907407938771.0k1.0k1.1k

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating-239117387527-14
    Cash from Investing-20-14-10-20-3-27-43
    Cash from Financing20616-22-2-10-11-7
    SummaryCapital Expenditure
    Free Cash Flow-45-6-1016364819-17
    FCF Margin

    Valuation

    Assumptions

    Current — NATHBIOGEN
    Price
    ₹161
    EPS (TTM)
    ₹21.63
    PE (TTM)
    7.4
    Profit growth
    5.1%

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (8.5×) and current (7.4×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹161
    vs
    Fair value · 15% return
    ₹82
    49%Overvalued

    At 5.1% growth and a 7× exit, ₹161 only delivers your return if you pay ₹82. The price is currently baking in 19% growth.

    EPS grows 5.1%/yr for 5 years, then fades to 6% over 2, exits at 7×.

    YearGrowthEPS (₹)
    FY275.1%22.73
    FY285.1%23.89
    FY295.1%25.11
    FY305.1%26.39
    FY315.1%27.74
    FY325.5% ·fade29.28
    FY336.0% ·fade31.03

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Learn to analyse Nath Bio-Genes (India) Limited

    Guides on how to read this kind of business and the numbers that matter.